TransMedics Group (TMDX) Earnings Date, Estimates & Call Transcripts $157.88 -1.26 (-0.79%) (As of 11:15 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 4EstimatedActual EPS (Jul. 31) $0.35 Beat By $0.14 Consensus EPS (Jul. 31) $0.21 Conference Call TranscriptConference Call AudioEarnings Press Release Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTMDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TMDX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Brownstone ResearchAI expert reveals new Nvidia predictionEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released my latest prediction and believe it or not, I’m advising NOT pour all your money into Nvidia right nowClick here to see why TransMedics Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.19)($0.03)($0.11) Q2 20242($0.09)$0.10$0.01 Q3 20242$0.03$0.06$0.05 Q4 20242($0.08)$0.22$0.07 FY 20248($0.33)$0.35$0.01 Q1 20251$0.07$0.07$0.07 Q2 20251$0.05$0.05$0.05 Q3 20251$0.25$0.25$0.25 Q4 20251$0.30$0.30$0.30 FY 20254$0.67$0.67 $0.67TMDX Earnings Date and InformationTransMedics Group last released its quarterly earnings results on July 31st, 2024. The reported $0.35 EPS for the quarter, beating the consensus estimate of $0.21 by $0.14. The business had revenue of $114.30 million for the quarter, compared to analysts' expectations of $98.84 million. Its revenue was up 117.7% compared to the same quarter last year. TransMedics Group has generated ($0.34) earnings per share over the last year (($0.34) diluted earnings per share). Earnings for TransMedics Group are expected to grow by 47.97% in the coming year, from $1.23 to $1.82 per share. TransMedics Group has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.Read More TransMedics Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/4/2024(Estimated)------- 7/31/2024Q2 2024$0.21$0.35+$0.14$0.35$98.84 million$114.30 million 4/30/2024Q1 2024($0.05)$0.35+$0.40$0.35$83.78 million$96.90 million 2/26/2024Q4 2023($0.10)$0.12+$0.22$0.12$68.49 million$81.20 million 11/6/2023Q3 2023($0.18)($0.12)+$0.06$0.54$48.05 million$66.43 million 8/3/2023Q2 2023($0.15)($0.03)+$0.12($0.03)$42.42 million$42.46 million 5/1/2023Q1 2023($0.25)($0.08)+$0.17($0.08)$36.05 million$41.60 million AI expert reveals new Nvidia prediction (Ad)Everyone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released my latest prediction and believe it or not, I’m advising NOT pour all your money into Nvidia right nowClick here to see why2/22/2023Q4 2022($0.28)($0.21)+$0.07($0.21)$23.60 million$31.38 million 11/3/2022Q3 2022($0.40)($0.25)+$0.15($0.25)$18.96 million$25.68 million 8/1/2022Q2 2022($0.32)($0.41)($0.09)($0.41)$16.26 million$20.52 million 5/3/2022Q1 2022($0.35)($0.38)($0.03)($0.38)$10.22 million$15.88 million 2/23/2022Q4 2021($0.43)($0.46)($0.03)($0.46)$7.66 million$9.67 million 11/9/2021Q3 2021($0.32)($0.47)($0.15)($0.47)$7.73 million$5.37 million 8/5/2021Q2 2021($0.26)($0.39)($0.13)($0.39)$7.88 million$8.17 million 5/4/2021Q1 2021($0.28)($0.29)($0.01)($0.29)$6.93 million$7.05 million 3/1/2021Q4 2020($0.25)($0.23)+$0.02($0.23)$6.12 million$7.63 million 11/4/2020Q3 2020($0.32)($0.19)+$0.13($0.19)$5.93 million$7.09 million 8/5/2020Q2 2020($0.42)($0.36)+$0.06($0.36)$3.24 million$3.39 million 5/6/2020Q1 2020($0.40)($0.42)($0.02)($0.42)$7.49 million$7.53 million 3/2/2020Q4 2019($0.39)($0.43)($0.04)($0.43)$6.51 million$6.06 million 11/6/2019Q3($0.47)($0.39)+$0.08($0.39)$6.67 million$7.21 million TransMedics Group Earnings - Frequently Asked Questions When is TransMedics Group's earnings date? TransMedics Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on TMDX's earnings history. What guidance has TransMedics Group issued on next quarter's earnings? TransMedics Group issued an update on its FY 2024 earnings guidance on Wednesday, July, 31st. The company issued revenue guidance of $425.0 million-$445.0 million, compared to the consensus revenue estimate of $401.4 million. Did TransMedics Group beat their earnings estimates last quarter? In the previous quarter, TransMedics Group (NASDAQ:TMDX) reported $0.35 earnings per share (EPS) to beat the analysts' consensus estimate of $0.21 by $0.14. Learn more on analysts' earnings estimate vs. TMDX's actual earnings. How can I listen to TransMedics Group's earnings conference call? The conference call for TransMedics Group's latest earnings report can be listened to online. Listen to Conference Call How can I read TransMedics Group's conference call transcript? The conference call transcript for TransMedics Group's latest earnings report can be read online. Read Transcript How much revenue does TransMedics Group generate each year? TransMedics Group (NASDAQ:TMDX) has a recorded annual revenue of $358.76 million. How much profit does TransMedics Group generate each year? TransMedics Group (NASDAQ:TMDX) has a recorded net income of -$25.03 million. TMDX has generated -$0.34 earnings per share over the last four quarters. What is TransMedics Group's EPS forecast for next year? TransMedics Group's earnings are expected to grow from $1.23 per share to $1.82 per share in the next year, which is a 47.97% increase. More Earnings Resources from MarketBeat Related Companies: ZYXI Earnings Results FONR Earnings Results CUTR Earnings Results SOLV Earnings Results PEN Earnings Results BLCO Earnings Results GKOS Earnings Results INSP Earnings Results STVN Earnings Results PRCT Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Micron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit Outlook This page (NASDAQ:TMDX) was last updated on 9/30/2024 by MarketBeat.com Staff From Our PartnersBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share TransMedics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
